Argenica Therapeutics LtdASX: AGN

Patient Dosing Milestone Achieved in Phase 2 Stroke Trial

Apr 10, 2024 at 2:47 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment